Atlas Trials

Perioperative Zanidatamab and Chemotherapy for HER2 Positive Gastroesophageal Cancer

Clinical trial NCT07477444 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07477444
Sponsor
Universitaire Ziekenhuizen KU Leuven
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Gastroesophageal Cancer
Start date
2026-06-01
Primary completion
2028-06-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.